Growth Differentiation Factor-15 (GDF-15): A Versatile Biomarker and Therapeutic Target with ANT BIO PTE. LTD.'s Antibody Solutions

1. Concept: Growth Differentiation Factor-15 (GDF-15)

Growth Differentiation Factor-15 (GDF-15), also known as Macrophage Inhibitory Cytokine-1 (MIC-1), is a member of the Transforming Growth Factor-β (TGF-β) superfamily. It is a 25 kDa homodimeric secreted protein, with its two polypeptide chains linked by disulfide bonds. As a stress-induced cytokine, GDF-15 is tightly regulated in a tissue-specific manner and modulated by inflammation- or stress-related mediators such as IL-1β, IL-2, TNF-α, and MCSF-1.

Under physiological conditions, circulating GDF-15 levels range from 200 to 1200 pg/ml. It is predominantly expressed in the placenta and prostate, with low basal levels in the heart, kidneys, liver, and pancreas. However, its expression is markedly induced under pathological stress (e.g., renal failure, chronic liver disease, cancer) or tissue injury, where it acts as an endocrine protective factor to maintain cellular and tissue homeostasis. GDF-15’s multifaceted roles span cancer biology, metabolism, cardiovascular health, and immune regulation, making it a versatile biomarker and therapeutic target.

2. Research Frontiers of GDF-15 in Disease Biology

Contemporary research on GDF-15 focuses on expanding its clinical utility and therapeutic potential. A key frontier is the development of GDF-15-targeted therapies—including neutralizing antibodies (e.g., ponsegromab, AZD8853) and analogs (e.g., CIN-109)—for indications such as cancer cachexia, obesity, and immunotherapy-refractory tumors. Another prominent direction involves validating GDF-15 as a companion diagnostic biomarker for risk stratification in cardiovascular diseases (e.g., heart failure, acute coronary syndrome) and cancer prognosis. Additionally, research is exploring the molecular mechanisms underlying GDF-15’s role in immune evasion and metabolic regulation, aiming to identify novel therapeutic strategies. Furthermore, advancements in high-sensitivity detection tools are enhancing GDF-15’s utility in early disease diagnosis and treatment monitoring.

3. Research Significance of GDF-15

GDF-15 research holds profound implications for addressing unmet clinical needs across multiple disease areas:

• Cancer diagnosis and prognosis: GDF-15 is one of the most highly overexpressed soluble factors in breast, colon, pancreatic, and esophageal cancers. It distinguishes malignant from benign conditions and predicts tumor invasion, metastasis, and survival, serving as a robust prognostic marker.
• Metabolic disorder management: As an "anorexigenic hormone," GDF-15 regulates food intake and energy expenditure via the GDF15-GFRAL-RET pathway, offering potential for obesity and non-alcoholic fatty liver disease (NAFLD) treatment.
• Cardiovascular risk stratification: GDF-15 is an independent predictor of mortality in acute coronary syndrome (ACS) and heart failure, with levels correlating with disease severity. It aids in the diagnosis and prognosis of heart failure with preserved ejection fraction (HFpEF).
• Immune modulation: GDF-15 exhibits anti-inflammatory effects in sepsis and regulates tumor immune evasion, providing new avenues for immunotherapy development.
• Translational potential: Clinical trials of GDF-15-targeted agents validate its utility as a therapeutic target, driving the development of novel treatments for cachexia, obesity, and cancer.

4. Relevant Mechanisms, Research Methods and Product Applications

4.1 Core Mechanisms of GDF-15 in Health and Disease

Cancer Biology

GDF-15 promotes tumor progression and metastasis by inducing epithelial-mesenchymal transition (EMT) and inhibiting anti-tumor immunity. It suppresses T-cell activation and dendritic cell maturation, enabling tumor immune evasion. Elevated GDF-15 levels correlate with increased tumor burden and poor clinical outcomes.

Metabolic Regulation

GDF-15 binds to its sole receptor GFRAL (GDNF family α-like receptor) in the hindbrain, recruiting the receptor tyrosine kinase RET to form a heterodimeric complex. This activates intracellular signaling pathways (MEK/ERK, PI3K/AKT, PLC/PKC), modulating the vagosympathetic nervous system, delaying gastric emptying, and reducing food intake—ultimately lowering body weight and improving glucose homeostasis.

Cardiovascular Function

GDF-15 is upregulated in response to myocardial injury and inflammation. It plays a protective role by reducing oxidative stress and fibrosis, but sustained elevation indicates severe cardiovascular dysfunction and predicts adverse outcomes.

Immune Modulation

In sepsis, GDF-15 inhibits excessive inflammatory responses by suppressing the production of pro-inflammatory cytokines (e.g., IL-6, TNF-α). GDF-15 knockout mice exhibit enhanced inflammation and organ damage, while overexpression confers protection.

4.2 Key Research Methods for GDF-15 Detection

• Immunoassays: ELISA and luminescence-based platforms are the gold standard for quantifying GDF-15 in serum, plasma, and tissue samples, offering high sensitivity and specificity.
• Western Blot: Qualitative and semi-quantitative analysis of GDF-15 protein expression in cell lysates and tissue homogenates.
• Immunohistochemistry (IHC): Visualization of GDF-15 localization in tumor and tissue samples, supporting mechanistic studies.
• Clinical cohort studies: Prospective and retrospective analyses to validate GDF-15’s prognostic and diagnostic value in disease-specific populations.

4.3 Product Applications of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. delivers high-performance antibody solutions for GDF-15 research and clinical detection through its Starter sub-brand—specializing in recombinant antibodies. All products are developed using advanced recombinant rabbit monoclonal antibody platforms, validated for sensitivity and specificity, and comply with EU 98/79/EC, ISO9001, and ISO13485 certifications. Key offerings include:

• GDF-15 Recombinant Rabbit mAbs: Catalog numbers S0B3295 (SDT-1012-69), S0B3294 (SDT-1012-78), S0B3293 (SDT-1012-55), and S0B3292 (SDT-1012-35) form a high-sensitivity antibody pair. Validated on luminescence platforms, they exhibit antigen sensitivity ≤100 pg/ml and excellent dilution gradients, ensuring accurate quantification of GDF-15 in biological samples.
• Application versatility: These antibodies support ELISA kit development, Western blot analysis, and IHC, catering to research and diagnostic needs in oncology, cardiology, and metabolism. Their high specificity minimizes cross-reactivity, enabling reliable detection of GDF-15 in complex matrices.

These products provide global partners with high-quality raw materials for GDF-15 detection, facilitating the development of diagnostic tools and advancing translational research.

5. Brand Mission of ANT BIO PTE. LTD.

ANT BIO PTE. LTD. is dedicated to empowering global life science research and clinical practice through high-quality, innovative reagents and professional services. As a leading provider of life science solutions, the company offers a comprehensive portfolio including antibodies, recombinant proteins, ELISA kits, and general laboratory reagents, with three specialized sub-brands: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Leveraging advanced R&D platforms—including recombinant antibody development (rabbit/mouse monoclonal), protein expression systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—ANT BIO PTE. LTD. adheres to the principles of "precision, reliability, and customer-centricity." The company strives to deliver cost-effective products and tailored support to researchers, clinicians, and biopharmaceutical partners, accelerating the translation of scientific discoveries into improved patient care and advancing global health.

6. Related Product List

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.